New Therapeutic Option for Patients with metastatic castration-resistant Prostate Cancer Talazoparib in combination with Enzalutamide prolongs progression-free Survival

被引：0
|
作者：
Ruedesheim, Sabine M.
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [31] Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
    Attard, Gerhardt
    de Bono, Johann S.
    Logothetis, Christopher J.
    Fizazi, Karim
    Mukherjee, Som D.
    Joshuas, Anthony M.
    Schrijvers, Dirk
    van den Eertwegh, Alfons J. M.
    Li, Weimin
    Molina, Arturo
    Griffin, Thomas W.
    Kheoh, Thian
    Ricci, Deborah S.
    Zelinsky, Kathy
    Rathkopf, Dana E.
    Scher, Howard I.
    Ryan, Charles J.
    CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1621 - 1627
  • [32] Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?
    Atakan, Demir
    Ozkan, Alan
    Guven, Mert Aslihan
    Sinan, Koca
    JOURNAL OF BUON, 2020, 25 (03): : 1625 - 1630
  • [33] Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
    Morris, Michael J.
    Rathkopf, Dana E.
    Novotny, William
    Gibbons, Jacqueline A.
    Peterson, Amy C.
    Khondker, Zakaria
    Ouatas, Taoufik
    Scher, Howard I.
    Fleming, Mark T.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3774 - 3781
  • [34] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 Phase III study design
    Agarwal, Neeraj
    Azad, Arun
    Shore, Neal D.
    Carles, Joan
    Fay, Andre P.
    Dunshee, Curtis
    Karsh, Lawrence Ivan
    Paccagnella, Maria Luisa
    Di Santo, Nicola
    Elmeliegy, Mohamed
    Lin, Xun
    Czibere, Akos
    Fizazi, Karim
    FUTURE ONCOLOGY, 2022, 18 (04) : 425 - 436
  • [36] Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
    Lin, Ting-Ting
    Chen, Ye-Hui
    Wu, Yu-Peng
    Chen, Shao-Zhan
    Li, Xiao-Dong
    Lin, Yun-Zhi
    Chen, Shao-Hao
    Zheng, Qing-Shui
    Wei, Yong
    Xu, Ning
    Xue, Xue-Yi
    JOURNAL OF CANCER, 2019, 10 (22): : 5608 - 5613
  • [37] Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
    Sanford, Mark
    DRUGS, 2013, 73 (15) : 1723 - 1732
  • [38] Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer
    Badrising, Sushil K.
    van der Noort, Vincent
    Hamberg, Paul
    Coenen, Jules L. L. M.
    Aarts, Maureen J.
    van Oort, Inge M.
    van den Eertwegh, Alfons J. M.
    Los, Maartje
    van den Berg, H. Pieter
    Gelderblom, Hans
    Vrijaldenhoven, Suzan
    Kerver, Emile D.
    van Voorthuizen, Theo
    de Jong, Igle J.
    Haanen, John B.
    Bergman, Andries M.
    ONCOLOGY, 2016, 91 (05) : 267 - 273
  • [39] A phase Ia/Ib study of talazoparib in combination with tazemetostat in metastatic castration-resistant prostate cancer (mCRPC).
    Choudhury, Atish Dipankar
    Xie, Wanling
    Tewari, Alok
    Miyamoto, David Tomoaki
    Kochupurakkal, Bose
    Ellis, Leigh
    Bandel, Matthew
    Leisner, Claire
    Shapiro, Geoffrey
    D'Andrea, Alan D.
    Van Allen, Eliezer Mendel
    Freedman, Matthew
    Taplin, Mary-Ellen
    Beltran, Himisha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Banna, Giuseppe L.
    Urzia, Valeria
    Benanti, Chiara
    Pitre, Alessandra
    Lipari, Helga
    Di Quattro, Rosario
    De Giorgi, Ugo
    Schepisi, Giuseppe
    Basso, Umberto
    Bimbatti, Davide
    Rundo, Francesco
    Libra, Massimo
    Malatino, Lorenzo
    SUPPORTIVE CARE IN CANCER, 2020, 28 (10) : 4687 - 4695
12345